Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Leukemia is a group of cancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells.
The report details the trend, potential and market size of Leukemia Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Leukemia Therapeuticsmarket, defines the market attractiveness level of Leukemia Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Leukemia Therapeutics industry, describes the types of Leukemia Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Leukemia Therapeutics market and the development prospects and opportunities of Leukemia Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Leukemia Therapeutics market in Chapter 13.
By Player:
Celgene
Clavis Pharma
GlaxoSmithKline
Pfizer
ERYtech Pharma
Biogen Idec
Eisai
Cephalon
Novartis
Bristol-Myers Squibb
Genmab
Roche
By Type:
Gleevec
Sprycel
Tasigna
Clolar
Others
By End-User:
Hospital
Clinic
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Leukemia Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Leukemia Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Leukemia Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Leukemia Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Leukemia Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Leukemia Therapeutics Consumption (2017-2022)
-
7.2 United States Leukemia Therapeutics Consumption (2017-2022)
-
7.3 Europe Leukemia Therapeutics Consumption (2017-2022)
-
7.4 China Leukemia Therapeutics Consumption (2017-2022)
-
7.5 Japan Leukemia Therapeutics Consumption (2017-2022)
-
7.6 India Leukemia Therapeutics Consumption (2017-2022)
-
7.7 South Korea Leukemia Therapeutics Consumption (2017-2022)
8 Region and Country-wise Leukemia Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Leukemia Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Leukemia Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Leukemia Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Leukemia Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Leukemia Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Leukemia Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Leukemia Therapeutics Consumption Forecast (2022-2028)
9 Global Leukemia Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Leukemia Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Gleevec Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Sprycel Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Tasigna Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Clolar Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Leukemia Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
10 Global Leukemia Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Leukemia Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Gleevec Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Sprycel Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Tasigna Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Clolar Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Leukemia Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
11 Global Leukemia Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Leukemia Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Leukemia Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Leukemia Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Leukemia Therapeutics Market Competitive Analysis
-
14.1 Celgene
-
14.1.1 Celgene Company Details
-
14.1.2 Celgene Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Celgene Leukemia Therapeutics Product and Service
-
14.2 Clavis Pharma
-
14.2.1 Clavis Pharma Company Details
-
14.2.2 Clavis Pharma Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Clavis Pharma Leukemia Therapeutics Product and Service
-
14.3 GlaxoSmithKline
-
14.3.1 GlaxoSmithKline Company Details
-
14.3.2 GlaxoSmithKline Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline Leukemia Therapeutics Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Leukemia Therapeutics Product and Service
-
14.5 ERYtech Pharma
-
14.5.1 ERYtech Pharma Company Details
-
14.5.2 ERYtech Pharma Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 ERYtech Pharma Leukemia Therapeutics Product and Service
-
14.6 Biogen Idec
-
14.6.1 Biogen Idec Company Details
-
14.6.2 Biogen Idec Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Biogen Idec Leukemia Therapeutics Product and Service
-
14.7 Eisai
-
14.7.1 Eisai Company Details
-
14.7.2 Eisai Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eisai Leukemia Therapeutics Product and Service
-
14.8 Cephalon
-
14.8.1 Cephalon Company Details
-
14.8.2 Cephalon Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Cephalon Leukemia Therapeutics Product and Service
-
14.9 Novartis
-
14.9.1 Novartis Company Details
-
14.9.2 Novartis Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis Leukemia Therapeutics Product and Service
-
14.10 Bristol-Myers Squibb
-
14.10.1 Bristol-Myers Squibb Company Details
-
14.10.2 Bristol-Myers Squibb Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bristol-Myers Squibb Leukemia Therapeutics Product and Service
-
14.11 Genmab
-
14.11.1 Genmab Company Details
-
14.11.2 Genmab Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Genmab Leukemia Therapeutics Product and Service
-
14.12 Roche
-
14.12.1 Roche Company Details
-
14.12.2 Roche Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Roche Leukemia Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Leukemia Therapeutics
-
Figure Leukemia Therapeutics Picture
-
Table Global Leukemia Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Leukemia Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Leukemia Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Leukemia Therapeutics Consumption by Country (2017-2022)
-
Figure United States Leukemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Leukemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Leukemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Leukemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Leukemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Leukemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Leukemia Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Leukemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Leukemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Leukemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Leukemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Leukemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Leukemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gleevec Consumption and Growth Rate (2017-2022)
-
Figure Global Sprycel Consumption and Growth Rate (2017-2022)
-
Figure Global Tasigna Consumption and Growth Rate (2017-2022)
-
Figure Global Clolar Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Gleevec Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sprycel Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tasigna Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clolar Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Leukemia Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Leukemia Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Leukemia Therapeutics Product and Service
-
Table Clavis Pharma (Foundation Year, Company Profile and etc.)
-
Table Clavis Pharma Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clavis Pharma Leukemia Therapeutics Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Leukemia Therapeutics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Leukemia Therapeutics Product and Service
-
Table ERYtech Pharma (Foundation Year, Company Profile and etc.)
-
Table ERYtech Pharma Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table ERYtech Pharma Leukemia Therapeutics Product and Service
-
Table Biogen Idec (Foundation Year, Company Profile and etc.)
-
Table Biogen Idec Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Leukemia Therapeutics Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Leukemia Therapeutics Product and Service
-
Table Cephalon (Foundation Year, Company Profile and etc.)
-
Table Cephalon Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cephalon Leukemia Therapeutics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Leukemia Therapeutics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Leukemia Therapeutics Product and Service
-
Table Genmab (Foundation Year, Company Profile and etc.)
-
Table Genmab Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genmab Leukemia Therapeutics Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Leukemia Therapeutics Product and Service
-
